Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Gronchi

Showing results (321-330 of 486) with videos related to

Pageof 49
Sort By:
BMC Cancer|August 28, 2016
Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic interventionDanique L M van Broekhoven, Dirk J Grünhagenl, Thijs van Dalen, et al.
The American Journal of Surgical Pathology|January 13, 2015
Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcomaAlessandro Gronchi, Paola Collini, Rosalba Miceli, et al.
Cancer|August 6, 2013
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation studyChiara Colombo, Rosalba Miceli, Alexander J Lazar, et al.
Annals of Surgical Oncology|April 16, 2025
ASO Visual Abstract: Use of Risk-Prediction Models (RPMs) for Clinical Decision Making in Soft-Tissue Sarcomas in the Extremities (eSTS): A Survey StudyAnouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Acta Oncologica (Stockholm, Sweden)|April 23, 2017
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 studyRobin J Young, Saskia Litière, Michela Lia, et al.
British Journal of Cancer|June 23, 2017
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcomaBruno Vincenzi, Silvia Stacchiotti, Paola Collini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body sizeAndrea Ferrari, Rosalba Miceli, Cristina Meazza, et al.
Annals of Surgical Oncology|February 1, 2025
Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma CliniciansAnouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Medical Oncology (Northwood, London, England)|February 22, 2014
Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescentsCristina Meazza, Roberto Luksch, Primo Daolio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 14, 2018
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trialPiotr Rutkowski, Louie Gaston, Aneta Borkowska, et al.
Pageof 49

Showing results (321-330 of 486) with videos related to

Sort By:
Pageof 49
BMC Cancer|August 28, 2016
Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic interventionDanique L M van Broekhoven, Dirk J Grünhagenl, Thijs van Dalen, et al.
The American Journal of Surgical Pathology|January 13, 2015
Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcomaAlessandro Gronchi, Paola Collini, Rosalba Miceli, et al.
Cancer|August 6, 2013
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation studyChiara Colombo, Rosalba Miceli, Alexander J Lazar, et al.
Annals of Surgical Oncology|April 16, 2025
ASO Visual Abstract: Use of Risk-Prediction Models (RPMs) for Clinical Decision Making in Soft-Tissue Sarcomas in the Extremities (eSTS): A Survey StudyAnouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Acta Oncologica (Stockholm, Sweden)|April 23, 2017
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 studyRobin J Young, Saskia Litière, Michela Lia, et al.
British Journal of Cancer|June 23, 2017
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcomaBruno Vincenzi, Silvia Stacchiotti, Paola Collini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body sizeAndrea Ferrari, Rosalba Miceli, Cristina Meazza, et al.
Annals of Surgical Oncology|February 1, 2025
Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma CliniciansAnouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Medical Oncology (Northwood, London, England)|February 22, 2014
Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescentsCristina Meazza, Roberto Luksch, Primo Daolio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 14, 2018
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trialPiotr Rutkowski, Louie Gaston, Aneta Borkowska, et al.
Pageof 49